Blog
Image: Stock Catalog/Flickr
Adam R. Houston | The Access to Drugs in Exceptional Circumstances pathway allows a jurisdiction to temporarily import a drug or vaccine not approved by Health Canada, but approved in the U.S., the E.U. or Switzerland.
News
Photo: flickr/ Nicole Mays
Michael Geist | While protection for biologics is not well understood by the public, at issue is billions of dollars and access to cutting-edge medicines.
Blog
Image: Bill Brooks/flickr
Scott Sinclair | The release of the final Trans-Pacific Partnership text shows that the trade deal has worrying implications for Canada, binding our country to a regulatory regime that would lock in high drug costs.
Blog
Stuart Trew | The federal government is about to sign a trade deal with Europe that would increase the cost even more in exchange for "illusory" gains in pharmaceutical research and development.
Blog
Karl Nerenberg | The House voted down a bill designed to save millions of lives in the developing world. It was a very tight vote. Many Conservatives who once supported the idea switched sides.
Blog
Activists gather outside health ministers meeting to urge support for medicare.
Adrienne Silnicki | While we applaud the Council of the Federation for taking the first steps towards a national pharmacare plan, we are disappointed with the federal government's plan to continue rewarding big pharma.
Blog
Photo: e-Magine Art/Flickr
Guillaume Hebert | The time has come to assess how effective policies regarding the pharmaceutical industry are. For some 20 years, Quebec has put everything in place to attract giants of this powerful industry.
Podcast
Meghan Murphy | Barbara Marshall speaks at The Medicalization of Sex conference in Vancouver about the medicalization of late-life sexuality and the ways in which sex and gender are constructed around aging bodies.
Podcast
Redeye
Mordecai Briemberg | Barbara Mintzes is co-author of the recent book Sex, Lies and Pharmaceuticals, examining how the industry is implicated in the discovery of a new women's illness: female sexual dysfunction.
Columnists
Ralph Surette | Canadians pay 16 to 40 per cent more for drugs than the average of industrialized countries. A national Pharmacare program would save Canada over $10 billion a year on its $25-billion drug bill.